Key Takeaways
- Steven D. Harr, CEO of Sana Biotechnology, earned $2,903,010 in 2025, a sharp decline from $8,788,580 in 2024.
- Institutional investors show mixed activity, with significant sell-offs by some and purchases by others in recent months.
- Analysts maintain positive outlooks for $SANA, with a median price target of $7.0.
Executive Compensation Overview
Sana Biotechnology, Inc. reported that its President and CEO, Dr. Steven D. Harr, received a compensation package totaling $2,903,010 in 2025. This marks a dramatic decrease of 202.74% from his $8,788,580 earnings in 2024, according to the firm’s DEF14A filing submitted to the SEC on April 24, 2026.
Institutional Investor Activity
The recent quarter revealed varied actions among institutional investors regarding $SANA stock. Specifically, 104 investors increased their holdings while 79 reduced them. Notably, Citadel Advisors LLC significantly divested by removing 6,538,436 shares, accounting for a staggering 99.8% reduction. In contrast, BlackRock, Inc. added 2,997,391 shares, enhancing their stake by 26.7%.
Additional significant transactions included Baillie Gifford & Co. selling 4,827,438 shares, while Balyasny Asset Management and State Street Corp. made smaller increases to their portfolios.
Analyst Ratings and Price Targets
Despite the fluctuations in institutional investments, Wall Street analysts remain optimistic about $SANA. Over the last few months, four firms issued buy ratings, indicating confidence in the company’s prospects. Notable endorsements include a buy rating by B of A Securities and an outperform rating from both HC Wainwright & Co. and Wedbush.
Several analysts also established recent price targets for $SANA, with a median target of $7.0. Martin Fan from Wedbush and Emily Bodnar from HC Wainwright both set this price target on separate occasions. Reni J. Benjamin from Citizens set a higher target of $8.0.
Overall, the mixed investor sentiment paired with analyst confidence suggests a nuanced view of Sana Biotechnology’s potential trajectory in the upcoming term.
The content above is a summary. For more details, see the source article.